Suspensions Lecture Notes

Suspensions Part 2

Learning Outcomes

  • Discuss approaches to formulation of suspensions
  • Discuss the typical ingredients found in different types of pharmaceutical suspensions

Formulation of Suspensions

  • Particles are the starting point.
  • Wetting and dispersion medium are added.
  • This leads to a uniform dispersion of deflocculated particles.
  • Two pathways from here:
    • Deflocculated Suspension:
      • Incorporate a structured vehicle resulting in the final product.
    • Flocculated Suspension:
      • Add a flocculating agent to get a flocculated suspension.
      • Incorporate a structured vehicle to get a flocculated suspension in a structured vehicle as the final product.
      • Another option is to proceed with the flocculated suspension as a final product.

Structured Vehicle

  • Aqueous solutions of polymeric materials are used.
  • Examples include methylcellulose, carboxymethylcellulose, bentonite, and carbomers.
  • Hydrocolloids are typically negatively charged in solution.
  • These act as viscosity-increasing suspending agents.
  • The concentration used depends on the consistency required.

Controlled Flocculation

  • A deflocculated, wetted dispersion of powder is flocculated using a flocculating agent.
  • The goal is to control the amount of flocculating agent to achieve maximum sedimentation volume.
  • Reflection point: What are 3 types of agents we can use as flocculating agents? How do they produce flocculation?

Formulation Excipients

  • Flavors, sweeteners, and colors are added for palatability.
  • Antimicrobial preservatives are necessary to prevent microbial growth.
  • Buffers maintain the pH of the suspension.
  • Chemical stabilizers prevent degradation of the drug.
  • Density and viscosity modifiers/suspending agents improve physical stability.
  • Wetting agents aid in dispersing the drug particles.
  • Flocculation modifiers control the flocculation process.

Flavors, Sweeteners, and Colors

  • Added to make the suspension palatable, especially for children.
  • The intensity of taste is less than in solutions due to only a small amount being in solution, but taste still needs consideration.
  • Suspensions are often used for children because they prefer sweet and fruity tastes.
  • Bitter drugs are best masked by bitter tastes like grapefruit.
  • The effect of colors and flavors on the physical behavior of suspensions is likely limited due to the small amounts added.

Sweeteners

  • Sucrose was commonly used but has concerns related to dental caries and diabetes glucose control.
  • Artificial sweeteners are sweeter than sugar, so less is required; examples include sodium saccharin, potassium acesulfame, and aspartame.
  • They may affect the electrical double layer.
  • Aspartame breaks down to phenylalanine, requiring caution in patients with phenylketonuria.

Sweeteners - Details

  • Saccharides:
    • Sucrose: Up to 80% concentration is used.
  • Polyols:
    • Mannitol: Has a cooling effect, is considered noncaloric, fairly expensive, and can cause diarrhea.
    • Sorbitol: Half as sweet as sucrose, considered noncaloric, and can cause diarrhea.
  • Synthetic:
    • Sodium Saccharin: 500 times as sweet as sucrose and inexpensive.
    • Aspartame: Has good acid stability.

Antimicrobial Preservatives

  • Water necessitates the use of preservatives such as sorbic acid, benzoic acid, parabens, sucrose, and benzalkonium chloride.
  • Sucrose has preservative action at >= 67% w/v.
  • Ideally, preservatives do not interfere with DLVO behavior.
  • Preservatives can affect the density and viscosity of the system, which can impact sedimentation.

Antimicrobial Preservatives - Benzalkonium Chloride (BZK)

  • Typically used in aqueous eye drop formulations at 0.01% w/w.
  • It's a cationic surfactant that dissociates to produce ClCl^- ions and a long-chain ionized surfactant moiety.
  • BZK could affect DLVO behavior.
  • It's not a "pure" product; batches have molecules with varying hydrocarbon chain lengths.
  • Variability between batches may affect flocculation behavior.

Preservatives - Sorbic Acid and Benzoic Acid

  • Most effective in their unionized form.
  • They do not typically affect flocculation behavior.
  • The pKapK_a for sorbic acid is 4.8, and for benzoic acid is 4.2.
  • They are likely to be partially ionized at the usual pH of oral formulations.
  • Potassium sorbate and sodium benzoate are often used, which can introduce ions that may affect the diffuse layer and, consequently, flocculation.

Preservatives - Parabens

  • Do not ionize at pH conditions expected in pharmaceutical formulations.
  • Unlikely to interfere with flocculation.

Typical Preservatives and Concentration Ranges

  • Alcohols:
    • Ethanol: >20%
    • Propylene Glycol: 15-30%
    • Benzyl Alcohol: 0.5-3%
  • Quaternary Amines:
    • Benzalkonium Chloride: 0.004-0.02%
  • Acids:
    • Sorbic Acid: 0.05-0.2%
    • Benzoic Acid: 0.1-0.5%
  • Parabens:
    • Methylparaben: 0.2%
    • Propylparaben: 0.05%

Buffers

  • Mixtures of a weak acid or base and one of its salts.
  • Designed to maintain the pH of the aqueous vehicle within narrow limits.
  • May be needed to maintain a specific pH range for a particular administration route or to suppress drug solubility.
  • Ionic nature means buffers contribute charges to the formulation and may affect flocculation.
  • They may also affect the ionization state of other components, such as preservatives.

Chemical Stabilizers

  • Antioxidants (e.g., ascorbic acid, sodium metabisulfite) and chelating agents (e.g., EDTA or disodium edetate) are used.

Viscosity Modifiers

  • Also known as suspending agents.
  • Reduce sedimentation by increasing the viscosity of the medium.
  • A balance is needed between viscosity at rest and the ability to pour the liquid for dose measurement.
  • Examples include:
    • Cellulose-based materials (e.g., methylcellulose, carboxymethylcellulose, hydroxypropylcellulose).
    • Alginic acid.
    • Clays.
    • Gums (acacia, tragacanth).

Typical Suspending Agents

  • Cellulose Derivatives:
    • Methylcellulose: Pseudoplastic/plastic rheologic behavior, neutral ionic charge, 1-5% concentration range.
    • Hydroxypropyl Methylcellulose: Pseudoplastic rheologic behavior, neutral ionic charge, 0.3-2% concentration range.
    • Sodium Carboxymethylcellulose: Pseudoplastic rheologic behavior, anionic ionic charge, 1-2% concentration range.
    • Microcrystalline Cellulose with Sodium Carboxymethylcellulose: Plastic/thixotropic rheologic behavior, anionic ionic charge, 0.5-2% concentration range.
  • Clays:
    • Bentonite: Plastic/thixotropic rheologic behavior, anionic ionic charge, 1-6% concentration range.
    • Magnesium Aluminum Silicate: Plastic/thixotropic rheologic behavior, anionic ionic charge, 0.5-5% concentration range.
  • Polymers:
    • Carbomer: Plastic rheologic behavior, anionic ionic charge, 0.1-0.4% concentration range.
    • Povidone: Newtonian/Pseudoplastic rheologic behavior, neutral ionic charge, 5-10% concentration range.
  • Gums:
    • Xanthan gum: Plastic/thixotropic rheologic behavior, anionic ionic charge, 0.3-3% concentration range.
    • Carrageenan: Newtonian/Pseudoplastic rheologic behavior, anionic ionic charge, 1-2% concentration range.

Wetting Agents

  • Improve the flow of the vehicle over the particle surface.
  • Enhance the homogeneous distribution of particles throughout the formulation.
  • Reduce interfacial tension between the solid particles and the liquid medium.
  • Typically surfactants used below their critical micelle concentration (CMC).
  • Can affect the charge on the particle surface and DLVO behavior.

Flocculation Modifiers

  • Ions present in solution affect surface charge, Stern potential, and zeta potential.
  • Types include ionic modifiers, surfactants, and polymers.
  • NaCl may be added as a flocculation modifier; the effect depends on the ionic strength of the ion.
  • Multivalent ions such as CaCl2CaCl_2 will have a greater effect than monovalent salts (e.g., NaCl).

Injectable Suspensions

  • Can use aqueous or non-aqueous dispersion medium.
  • Some are available as powders that are re-dispersed just prior to injection.
  • Administer suspensions intramuscularly (IM) or subcutaneously (SC), but NOT intravenously (IV)!!!
  • Must be sterile, pyrogen-free, capable of being administered by syringe, isotonic, and non-irritating.
  • Usually contain 0.5-5% solid with a particle size <5µm.
  • Procaine penicillin is an example with a higher concentration of solid (30%).

Procaine Penicillin

  • Solubility of procaine penicillin is 1g in 250mL water.
  • The injection contains 1.5g in 3.4mL.
  • Administered intramuscularly (IM).
  • The drug slowly dissolves from crystals, giving peak levels in 2 hours.
  • Administered as a once-daily injection for 2-5 days.

Solvent Systems

  • Aqueous or non-aqueous solvents can be used.
  • Water is preferred for parenteral formulations.
  • Sometimes water is mixed with other water-miscible solvents such as ethanol, glycerin, or propylene glycol.
  • Care is needed, as some solvents can cause muscle damage or lysis of red blood cells.

Non-Aqueous Solvents

  • Water-immiscible solvents used in suspension injection formulations include fixed oils, ethyl oleate, isopropyl myristate, and benzyl benzoate.
  • Fixed oils must be fluid at room temperature and vegetable in origin.
  • Often need to add an antioxidant when using fixed oils.
  • Examples include sesame oil, peanut oil, and castor oil.

Manufacture of Injectable Suspensions

  • Sterilization and aseptic milling of active ingredients.
  • Sterilization of the vehicle.
  • Aseptic wetting and dispersion of active ingredients.
  • Aseptic mixing of bulk suspensions.
  • Aseptic filling of bulk suspension into suitable sterile containers.

Re-Constitutable Oral Suspensions

  • Commonly used for antibiotics.
  • Reconstituted and used over a short period (e.g., 14 days).
  • Desired attributes:
    • The powder blend must be a uniform mixture of appropriate concentrations of each ingredient.
    • During reconstitution, the powder must re-disperse easily and quickly in the aqueous vehicle.
    • Must be easily redispersed and poured by the patient to provide an accurate, uniform dose.
    • The final product must have acceptable appearance, odor, and taste.

Types of Ingredients in Re-Constitutable Oral Suspensions

  • Suspending agents.
  • Wetting agents.
  • Sweeteners.
  • Preservatives.
  • Flavors and colors.
  • Solid diluent.
  • Anticaking agents.
  • Flocculating agent.
  • Antioxidant.
  • Buffer.

Suspending Agents in Re-Constitutable Oral Suspensions

  • Should be easily dispersed by vigorous shaking during reconstitution.
  • Not recommended: agar, carbomer, methylcellulose.
  • Recommended: acacia, tragacanth, xanthan gum, povidone, silicon dioxide colloidal, Na-CMC.

Sweeteners in Re-Constitutable Oral Suspensions

  • A significant component as drugs frequently taste bitter.
  • Increased viscosity from sweeteners aids in suspending particles.
  • Sucrose can act as both a sweetener and viscosity enhancer, as well as a diluent for the dry mixture.
  • Other sweeteners: dextrose, mannitol, aspartame, sodium saccharin.

Wetting Agents in Re-Constitutable Oral Suspensions

  • Use the lowest concentration to avoid foaming and taste problems.
  • Polysorbate 80 is commonly used; it is nonionic and chemically compatible with cationic and anionic excipients and drugs.
  • Sodium lauryl sulfate (anionic) is also used.

Other Agents in Re-Constitutable Oral Suspensions

  • Flocculating agents are not commonly used because suspensions are redispersed frequently enough to prevent caking.
  • Buffers are used to maintain optimum pH; sodium citrate is commonly used.

Other Agents - Preservatives and Anticaking Agents

  • Suspending agents and sweeteners are good growth media for microorganisms; sucrose at high concentration can help prevent microbial growth.
  • Anticaking agents such as amorphous silica prevent poor powder flow and caking of dry powder mixtures due to moisture uptake.
  • As a desiccant, amorphous silica removes moisture from the dry mixture and helps maintain flow properties; it also provides some thermal insulation and is chemically inert.

Extemporaneous Preparation of Suspensions

  • Must obtain uniform, small particles of the drug, often achieved by grinding in a mortar.
  • Thoroughly wet the powder before mixing with the vehicle.
  • Hydrophilic materials are best wetted with a water-miscible liquid (glycerin).
  • Hydrophobic materials are often wetted with a surfactant, using only the minimum required.
  • The drug and wetting agent form a thick paste, then the vehicle is added with constant stirring.

Extemporaneous Preparation Considerations

  • Often made from tablets (consider if the tablet should be crushed).
  • Grind tablets to ensure uniform particle size.
  • Common suspending agents are Compound Tragacanth Powder or carboxymethylcellulose suspension APF.
  • Must also consider sweetening, flavoring, and preservation.

Suspending Agents and Vehicles for Compounding Suspensions

Suspending AgentVehicleFinal Concentration (%)Alcohol Content (%)pH
Acacia NF2.0-5.0
Carbomer resins NF0.5-5.0
Carboxymethylcellulose sodium USP0.5-1.5
Colloidal silicon dioxide NF1.5-3.5
Methylcellulose USP0.5-5.0
Tragacanth NF0.5-2.0
Cologel5
HH4-4.5
Ora-Plus0
Suspendol-S05.3-6